Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Gynecologic 1

Conditions

Breast Neoplasms 218Triple Negative Breast Neoplasms 17Carcinoma, Intraductal, Noninfiltrating 15Breast Neoplasms, Male 15Inflammatory Breast Neoplasms 13Lung Neoplasms 11Prostatic Neoplasms 10Neoplasms 10Neoplasm Metastasis 10Breast Carcinoma In Situ 9Brain Neoplasms 9Carcinoma, Ductal, Breast 7Melanoma 6Carcinoma, Non-Small-Cell Lung 6Recurrence 5Rectal Neoplasms 4Radiation Injuries 4Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Lymphocytic, Chronic, B-Cell 4Hodgkin Disease 4Dendritic Cell Sarcoma, Interdigitating 4Carcinoma, Renal Cell 4Carcinoma, Lobular 4Burkitt Lymphoma 4Testicular Neoplasms 3

Interventions

Radiotherapy 2fresolimumab 1enzalutamide 1Losartan 1Fenretinide 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Camurati-Engelmann Syndrome × Radiotherapy × Breast × Clear all
NCT01401062 2019-03-05

Fresolimumab and Radiotherapy in Metastatic Breast Cancer

Weill Medical College of Cornell University

Phase 2 Completed
23 enrolled 8 charts
Breast

Breast Neoplasms, Camurati-Engelmann Syndrome

NCT01402193 2014-06-25

Study of Arimidex and Radiotherapy Sequencing

Fudan University

Phase 3 Unknown
220 enrolled
Breast

Breast Neoplasms, Camurati-Engelmann Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡